AEMD Aethlon Medical, Inc. - Common Stock
$2,87
Precio · Ago 19, 2026
Fundamentales a fecha de Ago 13, 2026
Rango 52S
$1–$27
9% of range
Calificación del Analista
HOLD
7 analysts
Precio Objetivo
$16
+466% upside
P/E (TTM)
-0.1
ROE
-134.5%
Margen de Beneficio Neto
—
Acerca de Aethlon Medical, Inc. - Common Stock Descripción general de la empresa de Wikipedia
AEMD Instantánea de la Acción Precio, capitalización bursátil, P/E, BPA, ROE, deuda/capital, rango de 52 semanas
Precio
$2.87
Capitalización Bursátil
$901.5K
P/E (TTM)
-0.1
BPA (TTM)
$-10.61
Ingresos (TTM)
$0
Rendimiento div.
—
ROE
-134.5%
Deuda/Capital
—
Rango 52S
$1 – $27
AEMD Gráfico del Precio de la Acción OHLCV diario con indicadores técnicos — desplace, amplíe y personalice su vista
Configure
Rendimiento a 10 años Tendencias de ingresos, beneficio neto, márgenes y BPA
Ingresos y Beneficio Neto
$0
2021-03-31
→
2024-03-31
BPA
$-10.61
2022-03-31
→
2026-03-31
Flujo de caja libre
$-7M
2021-03-31
→
2026-03-31
Márgenes
—
Valoración Ratios P/E, P/S, P/B, EV/EBITDA: ¿está la acción cara o barata?
Métrica
Tendencia a 5 años
AEMD
Mediana de Pares
P/E (TTM)
-0.1
27.5
P/S (TTM) (P/V (TTM))
52.7
3.4
P/B (P/C)
0.2
0.6
Price / FCF (Precio / FCF)
-0.1
—
Rentabilidad Márgenes brutos, operativos y netos; ROE, ROA, ROIC
Métrica
Tendencia a 5 años
AEMD
Mediana de Pares
ROA
-104.5%
-102.7%
ROE
-134.5%
-142.6%
ROIC
-149.3%
—
Salud financiera Deuda, liquidez, solvencia — solidez del balance general
Métrica
Tendencia a 5 años
AEMD
Mediana de Pares
Current Ratio (Ratio corriente)
3.8
2.1
Quick Ratio (Ratio Rápido)
3.5
—
Crecimiento Crecimiento de ingresos, BPA y beneficio neto: interanual, CAGR a 3 años, CAGR a 5 años
Métrica
Tendencia a 5 años
AEMD
Mediana de Pares
Eficiencia de capital Rotación de activos, rotación de inventario, rotación de cuentas por cobrar
Métrica
Tendencia a 5 años
AEMD
Mediana de Pares
AEMD Consenso de analistas Opiniones de analistas alcistas y bajistas, precio objetivo a 12 meses, potencial alcista
VENTA
7 analistas
- Compra fuerte 0 0,0%
- Compra 0 0,0%
- Mantener 4 57,1%
- Venta 1 14,3%
- Venta fuerte 2 28,6%
Precio objetivo a 12 meses
2 analistas · 2026-08-17
Mediana
$16.25
← Por Debajo de Todos los Objetivos
$2.87
Mín
$7.50
Máx
$25.00
Objetivo mediano
$16.25
+466,2%
Objetivo medio
$16.25
+466,2%
Historial de Ganancias EPS real vs estimado, sorpresa %, tasa de aciertos, próxima fecha de resultados
Sorpresa Media
-12.0%
| Período | EPS Actual | EPS est. | Sorpresa |
|---|---|---|---|
| 31 de marzo de 2027 | $-4.02 | $-0.80 | — |
| 30 de junio de 2026 | $-4.02 | $-0.80 | -3.2% |
| 31 de marzo de 2026 | $-1.49 | $-2.06 | 0.56% |
| 31 de diciembre de 2025 | $-2.45 | $-2.47 | 0.02% |
| 30 de septiembre de 2025 | $-3.74 | $-3.74 | -0.00% |
| 30 de junio de 2025 | $-8.50 | $-8.77 | 0.27% |
| 31 de marzo de 2025 | $-79.70 | $-10.30 | -69.4% |
Comparación de pares (subindustria GICS) Métricas clave frente a competidores del sector
| Ticker | Capitalización Bursátil | P/E | Ingresos interanuales | Margen Neto | ROE | Margen Bruto |
|---|---|---|---|---|---|---|
| AEMD | $3M | -0.2 | — | — | -134.5% | — |
| TNON | — | — | — | — | — | — |
| IVF | — | -0.0 | 4.7% | — | — | — |
| VBIO | — | — | — | — | — | — |
| ABT | $250.18B | 33.7 | 5.7% | 14.7% | 13.1% | — |
Fundamentales Completos Todas las métricas por año — estado de resultados, balance general, flujo de caja
Estado de resultados 16
| Métrica | Tendencia | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | · | · | $0 | $574.2K | $294.2K | $659.1K | $650.2K | $229.6K | $149.6K | $392.1K | $886.6K | $762.4K | |
| R&D Expense | $2M | $2M | $3M | $3M | $2M | $2M | $927.0K | $896.0K | $586.0K | $673.0K | $782.0K | $1M | |
| SG&A Expense | $3M | $3M | $4M | $4M | $3M | $2M | $2M | $953.5K | $792.6K | $849.5K | $929.0K | $907.1K | |
| Operating Expenses | $7M | $9M | $13M | $12M | $11M | $9M | $7M | $6M | $5M | $6M | $5M | $5M | |
| Operating Income | $-7M | $-9M | $-13M | $-12M | $-10M | $-8M | $-6M | $-6M | $-5M | $-6M | $-4M | $-4M | |
| Interest Expense | · | $10.1K | · | · | · | · | · | · | · | · | $125.6K | $298.0K | |
| Interest Income | $156.5K | $298.1K | · | · | · | · | · | · | · | · | · | · | |
| Other Non-op | $142.2K | $-4M | · | · | · | $-1.6K | $-450.1K | $-220.5K | · | · | · | · | |
| Pretax Income | $-7M | $-13M | · | · | · | · | · | · | · | · | · | · | |
| Income Tax | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Net Income | $-7M | $-13M | $-12M | $-12M | $-10M | $-8M | $-6M | $-6M | $-6M | $-7M | $-5M | $-7M | |
| EPS (Basic) | $-10.61 | $-85.77 | $-38.87 | $-5.86 | $-0.71 | · | · | · | · | · | · | · | |
| EPS (Diluted) | $-10.61 | $-85.77 | $-38.87 | $-5.86 | $-0.71 | · | · | · | · | · | · | · | |
| Shares (Basic) | 673,945 | 156,085 | 314,097 | 2,053,744 | 14,756,967 | · | · | · | · | · | · | · | |
| Shares (Diluted) | 673,945 | 156,085 | 314,097 | 2,053,744 | 14,756,967 | · | · | · | · | · | · | · | |
| EBITDA | $-7M | $-9M | · | $-12M | $-10M | $-8M | $-6M | $-6M | $-5M | $-6M | $-4M | $-4M |
Balance general 23
| Métrica | Tendencia | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $5M | $6M | $5M | $15M | $17M | $10M | $10M | $4M | $7M | $2M | $2M | $855.6K | |
| Receivables | · | · | · | $0 | $128.0K | $149.1K | $206.7K | $0 | $74.8K | $0 | $199.5K | $193.3K | |
| Prepaid Expense | $332.1K | $448.5K | $506.0K | $557.6K | $956.6K | $341.1K | $229.6K | $210.0K | $181.4K | $37.6K | $53.3K | $73.1K | |
| Current Assets | $6M | $6M | $6M | $15M | $18M | $10M | $10M | $4M | $7M | $2M | $2M | $1M | |
| PP&E (Net) | $356.8K | $676.2K | $1M | $1M | $441.2K | $161.0K | $140.5K | $6.0K | $27.6K | $29.2K | $36.0K | $56.1K | |
| PP&E (Gross) | $2M | $2M | $2M | $990.0K | $813.4K | $585.9K | $526.0K | $374.4K | $376.9K | $352.1K | $394.4K | $385.1K | |
| Accum. Depreciation | $1M | $978.9K | $990.5K | $734.2K | $493.9K | $424.9K | $385.5K | $368.3K | $349.4K | $322.9K | $358.4K | $329.0K | |
| Intangibles | $0 | $550 | $1.1K | $1.6K | $2.2K | $57.0K | $57.5K | $66.7K | $75.8K | $85.0K | $94.2K | $103.3K | |
| Other Non-current Assets | · | · | · | · | · | · | · | · | · | · | $22.4K | $16.8K | |
| Total Assets | $6M | $7M | $8M | $18M | $19M | $11M | $10M | $4M | $7M | $2M | $3M | $1M | |
| Accounts Payable | $384.6K | $534.5K | $777.9K | $432.9K | $500.0K | $337.7K | $285.0K | $131.9K | $124.5K | $484.4K | $244.8K | $342.1K | |
| Short-term Debt | · | · | · | · | · | · | · | · | · | · | · | $0 | |
| Current Liabilities | $1M | $2M | $2M | $2M | $2M | $1M | $1M | $2M | $478.0K | $611.8K | $526.6K | $574.0K | |
| Capital Leases | $0 | $336.7K | $649.8K | $939.6K | $602.5K | $0 | $42.5K | $0 | · | · | · | · | |
| Total Liabilities | $1M | $2M | $2M | $2M | $2M | $1M | $1M | $2M | $1M | $1M | $1M | $729.2K | |
| Total Debt | · | · | · | · | · | · | · | · | · | · | · | $0 | |
| Common Stock | $314 | $259 | $329 | $2.3K | $15.4K | $12.2K | $9.4K | $1.3K | $17.7K | $8.8K | $7.6K | $6.7K | |
| Paid-in Capital | $180M | $173M | $160M | $157M | $147M | $129M | $121M | $108M | $106M | $94M | $88M | $82M | |
| Retained Earnings | $-175M | $-168M | $-155M | $-142M | $-130M | $-120M | $-112M | $-106M | $-99M | $-94M | $-87M | $-82M | |
| AOCI | $-32.7K | $-17.1K | $-6.9K | $-6.1K | $0 | · | · | · | · | · | · | · | |
| Stockholders' Equity | $5M | $5M | $6M | $15M | $17M | $9M | $9M | $2M | $6M | $676.4K | $2M | $615.5K | |
| Liabilities + Equity | $6M | $7M | $8M | $18M | $19M | $11M | $10M | $4M | $7M | $2M | $3M | $1M | |
| Shares Outstanding | 314,100 | 201,074 | 328,728 | 2,299,259 | 15,419,163 | 15,419,163 | 9,366,873 | 1,266,979 | 17,739,511 | 8,797,086 | 7,622,393 | 6,657,046 |
Flujo de Efectivo 12
| Métrica | Tendencia | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $323.7K | $339.6K | $359.1K | $240.9K | $123.7K | $39.9K | $26.4K | $30.7K | $35.7K | $32.4K | $38.5K | $37.4K | |
| Stock-based Comp | $278.5K | $415.2K | $1M | $1M | $750.6K | $779.4K | $844.0K | $1M | $1M | $2M | $202.8K | $416.5K | |
| Amort. of Intangibles | $550 | $550 | $550 | $550 | $54.8K | $550 | $9.2K | $9.2K | $9.2K | $9.2K | $9.0K | $9.0K | |
| Other Non-cash | $-449.1K | $5M | · | $231.9K | $-225.4K | $302.4K | $306.0K | $551.6K | $472.5K | $2M | $301.7K | $1M | |
| Operating Cash Flow | $-7M | $-8M | $-10M | $-11M | $-10M | $-7M | $-5M | $-4M | $-4M | $-4M | $-4M | $-5M | |
| CapEx | $3.7K | $0 | $250.9K | $943.1K | $349.2K | $59.9K | $151.7K | $0 | $24.8K | $16.4K | $9.3K | $0 | |
| Investing Cash Flow | $-3.7K | $0 | $-250.9K | $-943.1K | $-349.2K | $-59.9K | $-151.7K | $0 | $-24.8K | $-16.4K | $-9.3K | $0 | |
| Stock Issued | $7M | $5M | $1M | $9M | · | · | · | · | · | · | $6M | $5M | |
| Net Stock Activity | $7M | $4M | · | · | · | · | · | · | · | · | $6M | $5M | |
| Financing Cash Flow | $7M | $8M | $1M | $9M | $17M | $7M | $11M | $1M | $9M | $3M | $6M | $5M | |
| Net Change in Cash | $-473.7K | $69.6K | $-9M | $-3M | $7M | · | · | · | · | · | · | · | |
| Free Cash Flow | $-7M | $-8M | · | $-11M | $-10M | $-7M | $-5M | $-4M | $-4M | $-4M | $-4M | $-5M |
Rentabilidad 6
| Métrica | Tendencia | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | · | · | · | -2072.1% | -3542.5% | -1197.1% | -912.0% | -2612.5% | -3228.8% | -1555.4% | -494.6% | -523.7% | |
| Net Margin | · | · | · | -2094.9% | -3540.9% | -1196.6% | -980.3% | -2697.8% | -3795.9% | -1855.8% | -549.6% | -891.5% | |
| EBITDA Margin | · | · | · | -2030.1% | -3500.5% | -1191.0% | -908.0% | -2599.2% | -3205.0% | -1547.2% | -490.2% | -518.8% | |
| ROA | -104.5% | -171.6% | · | -65.1% | -46.0% | -67.6% | -84.6% | -136.5% | -86.7% | -578.4% | -158.5% | -299.6% | |
| ROE | -134.5% | -283.1% | · | -74.4% | -78.4% | -83.7% | -107.7% | -144.8% | -166.8% | -652.8% | -449.4% | 94.8% | |
| ROIC | -149.3% | · | · | · | · | · | · | · | · | · | · | · |
Liquidez y Solvencia 4
| Métrica | Tendencia | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 3.8 | 3.1 | · | 10.0 | 10.0 | 7.5 | 9.4 | 2.2 | 15.1 | 2.6 | 4.6 | 2.1 | |
| Quick Ratio | 3.5 | 2.9 | · | 9.7 | 9.4 | 7.3 | 9.2 | 2.1 | 14.7 | 2.5 | 4.4 | 1.8 | |
| Debt / Equity | · | · | · | · | · | · | · | · | · | · | · | 0.0 | |
| Interest Coverage | · | -924.1 | · | · | · | · | · | · | · | · | · | -11.4 |
Eficiencia 2
| Métrica | Tendencia | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | · | · | 0.0 | 0.0 | 0.1 | 0.1 | 0.1 | 0.0 | 0.3 | 0.3 | 0.3 | |
| Receivables Turnover | · | · | · | 9.0 | 2.1 | 3.7 | 6.3 | 6.1 | 4.0 | 3.9 | 4.5 | 5.3 |
Tasas de Crecimiento 1
| Métrica | Tendencia | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | · | · | · | 95.2% | -55.4% | · | · | · | · | · | · | · |
Valoración (TTM) 14
| Métrica | Tendencia | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $17.1K | $17.1K | $0 | $574.2K | $294.2K | $659.1K | $650.2K | $229.6K | $149.6K | $392.1K | $886.6K | $762.4K | |
| Net Income TTM | $-7M | $-13M | $-12M | $-12M | $-10M | $-8M | $-6M | $-6M | $-6M | $-7M | $-5M | $-7M | |
| Market Cap | $3M | $58M | · | $6.99B | $18.01B | $19.73B | $11.39B | $216.65B | $253.32B | $345.20B | $490.27B | $918.67B | |
| Enterprise Value | · | · | · | · | · | · | · | · | · | · | · | $918.67B | |
| P/E | -0.2 | -3.4 | -3.5 | -51.9 | -1645.1 | · | · | · | · | · | · | · | |
| P/S | 200.9 | 3383.1 | · | 12172.0 | 61222.7 | 29938.5 | 17518.8 | 943488.2 | 1693034.0 | 880442.3 | 552997.7 | 1204947.4 | |
| P/B | 0.7 | 11.3 | · | 464.0 | 1051.2 | 2092.4 | 1210.5 | 89335.6 | 41297.5 | 510361.3 | 315750.6 | 1492684.0 | |
| P / Tangible Book | 0.7 | 11.3 | 61.3 | 464.0 | 1060.1 | 2105.1 | · | · | · | · | · | · | |
| P / Cash Flow | -0.5 | -7.6 | · | -665.4 | -1843.9 | -2916.9 | -2191.5 | -50460.4 | -64776.5 | -98461.9 | -113245.0 | -181936.4 | |
| P / FCF | -0.5 | -7.6 | · | -610.5 | -1780.2 | -2891.3 | -2129.4 | -50460.4 | -64367.9 | -98002.6 | -113002.1 | -181936.4 | |
| EV / EBITDA | · | · | · | · | · | · | · | · | · | · | · | -232251.6 | |
| EV / FCF | · | · | · | · | · | · | · | · | · | · | · | -181936.3 | |
| EV / Revenue | · | · | · | · | · | · | · | · | · | · | · | 1204946.2 | |
| Earnings Yield | -484.5% | -29.8% | -28.9% | -1.9% | -0.06% | · | · | · | · | · | · | · |
Estado de resultados 12
| Métrica | Tendencia | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | · | · | · | · | · | · | · | · | · | · | · | · | · | $574.2K | $0 | $0 | |
| R&D Expense | $549.0K | $560.5K | $532.8K | $294.3K | $524.0K | $1M | $240.2K | $261.5K | $414.7K | $619.2K | $593.4K | $628.4K | $678.9K | $476.0K | $558.2K | $852.5K | |
| SG&A Expense | $662.5K | $698.0K | $741.6K | $521.4K | $735.4K | $716.4K | $816.4K | $958.4K | $752.0K | $764.9K | $979.2K | $850.8K | $1M | $829.1K | $1M | $2M | |
| Operating Expenses | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $3M | $3M | $2M | $4M | $3M | $3M | $3M | $3M | $4M | |
| Operating Income | $-2M | $-2M | $-2M | $-2M | $-2M | $-2M | $-2M | $-3M | $-3M | $-2M | $-4M | $-3M | $-3M | $-2M | $-3M | $-4M | |
| Other Non-op | · | · | · | · | $-5.9K | · | · | · | $0 | · | · | · | · | · | · | · | |
| Net Income | $-2M | $-2M | $-2M | $-1M | $-2M | $-6M | $-2M | $-3M | $-3M | $-2M | $-3M | $-3M | $-3M | $-2M | $-3M | $-4M | |
| EPS (Basic) | $-4.02 | $-3.57 | $-2.45 | $-3.74 | $-42.42 | $-56.85 | $-10.05 | $-16.11 | $-2.76 | $-34.93 | $-1.37 | $-1.22 | $-1.35 | $-2.59 | $-1.24 | $-1.84 | |
| EPS (Diluted) | $-4.02 | $-3.57 | $-2.45 | $-3.74 | $-42.42 | $-56.85 | $-10.05 | $-16.11 | $-2.76 | $-34.93 | $-1.37 | $-1.22 | $-1.35 | $-2.59 | $-1.24 | $-1.84 | |
| Shares (Basic) | 384,705 | -2,623,110 | 823,126 | 397,513 | 41,529 | -1,124,912 | 174,529 | 174,220 | 932,248 | -7,117,539 | 2,516,511 | 2,483,649 | 2,431,476 | -17,802,026 | 2,294,649 | 2,074,500 | |
| Shares (Diluted) | 384,705 | -2,623,110 | 823,126 | 397,513 | 41,529 | -1,124,912 | 174,529 | 174,220 | 932,248 | -7,117,539 | 2,516,511 | 2,483,649 | 2,431,476 | -17,802,026 | 2,294,649 | 2,074,500 | |
| EBITDA | $-2M | · | $-2M | $-2M | $-2M | · | $-2M | $-3M | $-3M | · | $-4M | $-3M | $-3M | · | $-3M | $-4M |
Balance general 20
| Métrica | Tendencia | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $5M | $5M | $7M | $6M | $4M | $6M | $5M | $7M | $9M | $5M | $8M | $10M | $13M | $15M | $17M | $20M | |
| Receivables | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $0 | $114.8K | |
| Prepaid Expense | $283.1K | $332.1K | $185.1K | $182.1K | $276.6K | $448.5K | $88.3K | $279.0K | $478.1K | $506.0K | $277.3K | $311.4K | $410.2K | $557.6K | $672.8K | $784.6K | |
| Current Assets | $6M | $6M | $7M | $6M | $4M | $6M | $5M | $7M | $10M | $6M | $8M | $10M | $13M | $15M | $18M | $21M | |
| PP&E (Net) | $293.1K | $356.8K | $434.2K | $514.0K | $593.7K | $676.2K | $762.1K | $843.6K | $929.3K | $1M | $1M | $1M | $1M | $1M | $1M | $1M | |
| PP&E (Gross) | · | $2M | · | · | · | $2M | · | · | · | $2M | · | · | · | $990.0K | · | · | |
| Accum. Depreciation | · | $1M | · | · | · | $978.9K | · | · | · | $990.5K | · | · | · | $734.2K | · | · | |
| Intangibles | · | $0 | $138 | $275 | $413 | $550 | $688 | $825 | $963 | $1.1K | $1.2K | $1.4K | $1.5K | $1.6K | $1.8K | $1.9K | |
| Total Assets | $6M | $6M | $8M | $7M | $5M | $7M | $7M | $9M | $11M | $8M | $10M | $13M | $16M | $18M | $21M | $23M | |
| Accounts Payable | $411.4K | $384.6K | $469.5K | $570.8K | $571.5K | $534.5K | $610.9K | $922.9K | $1M | $777.9K | $693.2K | $684.9K | $844.5K | $432.9K | $226.8K | $361.0K | |
| Current Liabilities | $1M | $1M | $1M | $1M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | |
| Capital Leases | · | $0 | $86.9K | $172.1K | $255.1K | $336.7K | $417.5K | $496.8K | $573.9K | $649.8K | $724.8K | $798.5K | $869.9K | $939.6K | $1M | $1M | |
| Total Liabilities | · | $1M | $1M | $2M | $2M | $2M | $2M | $3M | $3M | $2M | $3M | $3M | $3M | $2M | $3M | $3M | |
| Common Stock | $477 | $1.6K | $973 | $761 | $2.6K | $259 | $14.0K | $14.0K | $13.9K | $329 | $2.6K | $2.5K | $24.8K | $2.3K | $23.0K | $22.9K | |
| Paid-in Capital | $182M | $180M | $180M | $177M | $173M | $173M | $166M | $166M | $166M | $160M | $160M | $159M | $159M | $157M | $157M | $157M | |
| Retained Earnings | $-177M | $-175M | $-173M | $-171M | $-170M | $-168M | $-162M | $-160M | $-157M | $-155M | $-152M | $-149M | $-146M | $-142M | $-140M | $-137M | |
| AOCI | $-38.9K | $-32.7K | $-29.8K | $-26.4K | $-22.4K | $-17.1K | $-17.0K | $-4.0K | $-7.8K | $-6.9K | $-1.6K | $-9.6K | $-7.1K | $-6.1K | · | · | |
| Stockholders' Equity | $5M | $5M | $7M | $6M | $3M | $5M | $4M | $6M | $9M | $6M | $8M | $10M | $13M | $15M | $17M | $20M | |
| Liabilities + Equity | $6M | $6M | $8M | $7M | $5M | $7M | $7M | $9M | $11M | $8M | $10M | $13M | $16M | $18M | $21M | $23M | |
| Shares Outstanding | 477,402 | 1,570,449 | 973,213 | 761,318 | 2,598,711 | 201,074 | 13,986,669 | 13,961,998 | 13,937,327 | 328,728 | 2,596,538 | 2,492,908 | 24,835,321 | 2,299,259 | 22,969,349 | 22,946,232 |
Flujo de Efectivo 11
| Métrica | Tendencia | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $72.9K | $79.5K | $81.6K | $79.9K | $82.6K | $83.9K | $83.8K | $85.8K | $86.1K | $85.8K | $91.5K | $91.4K | $90.3K | $79.5K | $78.1K | $52.6K | |
| Stock-based Comp | $50.0K | $61.2K | $72.4K | $72.4K | $72.4K | $72.4K | $90.0K | $113.5K | $139.3K | $139.1K | $573.0K | $257.2K | $250.1K | $260.3K | $262.6K | $313.5K | |
| Other Non-cash | $-471.5K | · | · | · | $-108.2K | · | · | · | $598.5K | · | · | · | $459.4K | · | · | · | |
| Operating Cash Flow | $-2M | $-2M | $-2M | $-2M | $-2M | $-2M | $-2M | $-2M | $-2M | $-3M | $-2M | $-3M | $-2M | $-3M | $-2M | $-3M | |
| CapEx | $9.2K | $2.1K | · | · | $0 | $-2.2K | $2.2K | $0 | $0 | $4.9K | $8.8K | $6.8K | $230.4K | $11.3K | $151.5K | $739.2K | |
| Investing Cash Flow | $-9.2K | $-2.1K | · | · | $0 | $2.2K | $-2.2K | $0 | $0 | $-4.9K | $-8.8K | $-6.8K | $-230.4K | $-11.3K | $-151.5K | $-739.2K | |
| Stock Issued | $2M | $-848.5K | $4M | $4M | $0 | $-680.5K | $0 | $0 | $4M | $49.8K | $186.5K | $0 | $1M | $0 | $0 | $8M | |
| Net Stock Activity | $2M | · | · | · | $0 | · | · | · | $4M | · | · | · | $1M | · | · | · | |
| Financing Cash Flow | $2M | $-196.5K | $3M | $4M | $-5.4K | $2M | $-7.1K | $-3.8K | $5M | $42.6K | $177.1K | $-9.8K | $1M | $-2.6K | $-1.9K | $8M | |
| Net Change in Cash | $-92.7K | $-2M | $1M | $2M | $-2M | $686.2K | $-2M | $-2M | $4M | $-3M | $-2M | $-3M | $-2M | $-3M | $-2M | $5M | |
| Free Cash Flow | $-2M | · | · | · | · | · | · | · | $-2M | · | · | · | $-3M | · | · | · |
Rentabilidad 5
| Métrica | Tendencia | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -5047.0% | · | -4700.4% | -6642.4% | · | · | · | · | · | · | · | · | · | · | · | · | |
| Net Margin | -4947.0% | · | -4600.4% | -6542.4% | · | · | · | · | · | · | · | · | · | · | · | · | |
| EBITDA Margin | -4814.1% | · | -4700.4% | -6642.4% | · | · | · | · | · | · | · | · | · | · | · | · | |
| ROA | -26.8% | · | -27.7% | -18.4% | -21.1% | · | -20.7% | -25.9% | -18.9% | · | -22.2% | -16.9% | -19.9% | · | -13.4% | · | |
| ROE | -35.9% | · | -36.5% | -25.3% | -29.0% | · | -29.4% | -34.4% | -23.6% | · | -27.9% | -20.1% | -23.3% | · | -15.0% | · |
Liquidez y Solvencia 2
| Métrica | Tendencia | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 5.4 | · | 5.7 | 4.5 | 2.5 | · | 2.8 | 3.1 | 4.5 | · | 3.9 | 6.1 | 7.3 | · | 7.5 | 9.8 | |
| Quick Ratio | 4.8 | · | 5.5 | 4.2 | 2.3 | · | 2.7 | 2.9 | 4.3 | · | 3.8 | 5.9 | 7.1 | · | 7.2 | 9.4 |
Eficiencia 2
| Métrica | Tendencia | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | · | 0.0 | 0.0 | · | · | · | · | · | · | · | · | · | · | 0.0 | 0.0 | |
| Receivables Turnover | · | · | · | · | · | · | · | · | · | · | · | · | · | · | 0.0 | 0.0 |
Valoración (TTM) 10
| Métrica | Tendencia | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $17.1K | · | $17.1K | $17.1K | $17.1K | · | $17.1K | $17.1K | $17.1K | · | $17.1K | $17.1K | $17.1K | · | $17.1K | $149.1K | |
| Net Income TTM | $-7M | · | $-7M | $-8M | $-9M | · | $-11M | $-12M | $-12M | · | $-13M | $-13M | $-13M | · | $-12M | $-11M | |
| Market Cap | $391.5K | · | $3M | $6M | $31M | · | $962M | $525M | $557M | · | $455M | $459M | $7.15B | · | $5.15B | $10.65B | |
| P/E | -0.0 | · | -0.2 | -0.2 | -0.4 | · | -2.3 | -1.8 | -6.0 | · | -33.8 | -32.6 | -62.3 | · | -65.3 | -200.0 | |
| P/S | 22.9 | · | 157.5 | 333.6 | 1821.8 | · | 56218.0 | 30669.6 | 32569.6 | · | 26576.7 | 26797.6 | 417863.7 | · | 300586.2 | 71416.9 | |
| P/B | 0.1 | · | 0.4 | 1.0 | 9.1 | · | 222.0 | 87.2 | 64.0 | · | 59.8 | 44.5 | 545.6 | · | 297.8 | 535.9 | |
| P / Tangible Book | 0.1 | · | 0.4 | 1.0 | 9.1 | · | 222.1 | 87.2 | 64.0 | · | 59.8 | 44.5 | 545.7 | · | 297.8 | 535.9 | |
| P / Cash Flow | -0.2 | · | · | · | -18.2 | · | · | · | -319.0 | · | · | · | -2881.3 | · | · | · | |
| P / FCF | -0.2 | · | · | · | · | · | · | · | -319.0 | · | · | · | -2636.6 | · | · | · | |
| Earnings Yield | -6418.3% | · | -617.0% | -410.0% | -248.1% | · | -44.0% | -57.1% | -16.8% | · | -3.0% | -3.1% | -1.6% | · | -1.5% | -0.50% |
Estados Financieros Estado de resultados, balance general, flujo de caja — anual, últimos 5 años
Estado de resultados
| 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 | |
|---|---|---|---|---|---|
| Ingresos | — | — | $0 | $574.2K | $294.2K |
| Margen Operativo % | — | — | — | -2072.1% | -3542.5% |
| Beneficio neto | $-7M | $-13M | $-12M | $-12M | $-10M |
| EPS Diluido | $-10.61 | $-85.77 | $-38.87 | $-5.86 | $-0.71 |
Balance general
| 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 | |
|---|---|---|---|---|---|
| Ratio corriente | 3.8 | 3.1 | — | 10.0 | 10.0 |
| Ratio Rápido | 3.5 | 2.9 | — | 9.7 | 9.4 |
Flujo de Efectivo
| 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 | |
|---|---|---|---|---|---|
| Flujo de caja libre | $-7M | $-8M | — | $-11M | $-10M |
Mis Métricas Tu lista de seguimiento personal — filas seleccionadas de Fundamentales Completos
📊
Elige las métricas que te importan — haz clic en el ➕ junto a cualquier fila en Fundamentales Completos arriba.
Tu selección se guarda y te sigue en todos los tickers.
Propietarios institucionales (13F) 19 declarantes · $113K total · A fecha de 30 de junio de 2026
Instituciones que informan tener esta acción en su Formulario 13F trimestral de la SEC. Solo posiciones largas; un solo presentador puede aparecer dos veces para tramos de opciones separados. Las patas de put/call de compensación grandes suelen reflejar la creación de mercado o el inventario cubierto, no la convicción direccional.
Actividad institucional — Q2 2026 vs trimestre anterior
| Nuevas posiciones | Posiciones cerradas | Aumentado | Disminuido | Cambio neto de acciones |
|---|---|---|---|---|
| 9 (+3 vs trimestre anterior) | 2 (0 vs trimestre anterior) | 4 (+4 vs trimestre anterior) | 1 (+1 vs trimestre anterior) | +168K |
Comparado con Q1 2026. Las presentaciones del Formulario 13F de la SEC vencen dentro de los 45 días posteriores al final del trimestre, más un pequeño margen para los presentadores tardíos; los trimestres que aún se encuentran dentro de esa ventana se omiten en favor del par más reciente completamente reportado.
| Institución | Valor | Acciones | % de 13F rastreadas | Tipo |
|---|---|---|---|---|
| CITADEL ADVISORS LLC | $35 387 | 42 977 | 31,39% | Acciones |
| Shay Capital LLC | $25 585 | 31 072 | 22,70% | Acciones |
| Ikarian Capital, LLC | $11 827 | 14 364 | 10,49% | Acciones |
| JANE STREET GROUP, LLC | $8 864 | 10 765 | 7,86% | Acciones |
| Scientech Research LLC | $8 278 | 10 054 | 7,34% | Acciones |
| GEODE CAPITAL MANAGEMENT, LLC | $8 086 | 9 821 | 7,17% | Acciones |
| UBS Group AG | $7 305 | 8 876 | 6,48% | Acciones |
| Tower Research Capital LLC (TRC) | $5 213 | 6 331 | 4,62% | Acciones |
| MORGAN STANLEY | $2 035 | 2 472 | 1,81% | Acciones |
| HRT FINANCIAL LP | $59 | 72 743 | 0,05% | Acciones |
| Virtu Financial LLC | $23 | 27 815 | 0,02% | Acciones |
| JONES FINANCIAL COMPANIES LLLP | $15 | 17 | 0,01% | Acciones |
| MERCER GLOBAL ADVISORS INC /ADV | $13 | 16 | 0,01% | Acciones |
| Integrated Wealth Concepts LLC | $12 | 15 | 0,01% | Acciones |
| GROUP ONE TRADING LLC | $12 | 14 | 0,01% | Acciones |
| BlackRock, Inc. | $8 | 10 | 0,01% | Acciones |
| WELLS FARGO & COMPANY/MN | $2 | 3 | 0,00% | Acciones |
| NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO | $2 | 2 | 0,00% | Acciones |
| DANSKE BANK A/S | $1 | 1 | 0,00% | Acciones |
Informantes de la empresa 17 insiders · 9 directivos · 12 consejeros
| Insider | Rol | Última actividad | Acciones en propiedad | Compras 12m | Ventas 12m | Neto 12m |
|---|---|---|---|---|---|---|
| Charles J Fisher JR | Chief Executive Officer | 10 de febrero de 2022 A | 19 569 | 0 | 0 | $0 |
| Timothy C Rodell JR | Chief Executive Officer | 3 de abril de 2020 A | — | 0 | 0 | $0 |
| James A Joyce | Chairman, CEO, Secretary | 24 de agosto de 2016 G | 2 000 | 0 | 0 | $0 |
| James B Frakes | CFO & Sr. VP ? Finance | 10 de febrero de 2022 A | 2 483 | 0 | 0 | $0 |
| Rodney S Kenley | President | 9 de agosto de 2016 A | — | 0 | 0 | $0 |
| Lee D Arnold | Chief Scientific Officer | 1 de febrero de 2023 A | — | 0 | 0 | $0 |
| Steven P Larosa | Chief Medical Officer | 10 de febrero de 2022 A | — | 0 | 0 | $0 |
| Guy F. Cipriani | Sr. V.P., Chief Bus. Officer | 10 de febrero de 2022 A | 17 901 | 0 | 0 | $0 |
| Richard Tullis | VP, CHIEF SCIENCE OFFICER | 6 de junio de 2014 A | 526 750 | 0 | 0 | $0 |
| Nicolas Gikakis | Consejero | 30 de junio de 2026 F | 20 663 | 0 | 0 | $0 |
| Chetan Shah | Consejero | 30 de junio de 2026 F | 20 840 | 0 | 0 | $0 |
| Edward G Broenniman | Consejero | 30 de junio de 2026 F | 22 363 | 0 | 0 | $0 |
| Angela Rossetti | Consejero | 28 de abril de 2023 A | 167 649 | 0 | 0 | $0 |
| Sabrina Martucci Johnson | Consejero | 31 de marzo de 2022 F | 33 642 | 0 | 0 | $0 |
| Franklyn S Barry JR | Consejero | 9 de agosto de 2016 A | 106 593 | 0 | 0 | $0 |
| Phillip A Ward | — | 14 de marzo de 2014 A | — | 0 | 0 | $0 |
| Calvin M Leung | — | 23 de febrero de 2005 A | — | 0 | 0 | $0 |
Informantes de las presentaciones SEC Form 3/4/5; neto = solo P/S de mercado abierto
Activistas y propietarios del %+ 5 5 tenencias
Inversores que presentaron el Anexo 13D de la SEC — propiedad beneficiosa superior al % 5 con la intención de influir en el emisor (participaciones activistas, campañas de la junta directiva, M&A). Cada fila muestra el estado conocido más reciente de la posición de ese declarante.
| Declarante | Presentado | Participación | Estado | Propósito | Presentación |
|---|---|---|---|---|---|
| Ellen R. Weiner Family Revocable Trust | 18 de febrero de 2015 | — | Presentación inicial | — | SEC |
| Persona informante no revelada | 16 de diciembre de 2005 | — | Presentación inicial | — | SEC |
| Persona informante no revelada | 16 de diciembre de 2005 | — | Presentación inicial | — | SEC |
| Persona informante no revelada | 23 de noviembre de 2005 | — | Presentación inicial | Inversión pasiva | SEC |
| Persona informante no revelada | 23 de noviembre de 2005 | — | Presentación inicial | Inversión pasiva | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.